生物相容性食品矩阵对β-胡卜素,白醇和吉普诺酸的消化性和生物可用性
Nazir Ahmad1, Munza Khan1, Anwar Ali2
1Department of Nutritional Sciences, Government College University Faisalabad, Faisalabad, Pakistan.
Journal of the American Nutrition Association
|January 12, 2026
概括
食物矩阵显著影响营养吸收. 结构上被破坏的矩阵,如果汁和果汁,增强了β-胡卜素,白醇和gypenosides的生物可用性,提供了优越的吸收潜力.
科学领域:
- 营养科学 营养科学
- 食品化学 食品化学
- 药理动力学 药理动力学
背景情况:
- 关键化合物如β-胡卜素,白醇,和gypenosides的生物可用性对于他们的健康益处至关重要.
- 饮食矩阵显著影响这些生物活性化合物的吸收和有效性.
- 了解这些相互作用对于优化饮食摄入量和补充剂配方至关重要.
研究的目的:
- 为了评估β-胡卜素,白醇和gypenosides的体外可消化性和潜在生物利用性.
- 评估各种食物基质 (液体,乳制品,固体,水果/蔬菜) 对这些化合物的吸收的影响.
- 确定增强或阻碍β-胡卜素,白醇和gypenosides的生物可用性的食物矩阵.
主要方法:
- 在体外消化模型模拟人类的胃肠道.
- 在各种食物矩阵中分析β-胡卜素,复星和gypenosides度.
- 复合物回收的量化和潜在生物利用率的计算.
主要成果:
- 咖啡增强了白醇和gypenosides,但降低了β-胡卜素的生物可用性.
- 固体矩阵 (面包+) 和水果/蔬菜矩阵 (果汁,果汁) 一般提高了所有化合物的生物可用性.
- 乳制品矩阵显示出混合的结果,普通和含果酸奶受益于gypenosides,但由于蛋白质相互作用,不受益于β-胡卜素或白醇.
结论:
- 食物矩阵是对β-胡卜素,白醇和gypenosides的消化命运和生物可用性的关键决定因素.
- 结构上被破坏的矩阵,如果汁和果汁中的矩阵,提供了优越的吸收潜力.
- 矩阵组成,包括脂质,乳化剂和细胞结构,在调节化合物生物可用性方面发挥着关键作用.
相关概念视频
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
188
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
188
01:13Bioavailability: Overview
4.0K
Bioavailability refers to the proportion of an unaltered drug that, after administration, enters the systemic circulation and can be distributed to the desired action site. Factors such as gastrointestinal (GI) absorption and liver biotransformation influence the bioavailability of a drug when it is administered orally. When a drug is administered intravenously, it enters the systemic circulation directly; by definition, its bioavailability is assumed to be 100%. The bioavailability of an...
4.0K
01:17Bioavailability: Overview
341
Bioavailability refers to the proportion of an administered drug that reaches the systemic circulation in its active, unaltered form. It is a crucial pharmacokinetic parameter that determines the effectiveness of a drug in achieving its intended therapeutic outcomes. The route of administration significantly influences bioavailability, with intravenous administration achieving 100% bioavailability as the drug directly enters the bloodstream. In contrast, oral administration often results in...
341
01:23Factors Influencing Bioavailability: First-Pass Elimination
7.9K
When a drug is taken orally, it undergoes a journey starting from the gastrointestinal (GI) tract, passing through the portal vein, reaching the liver, and finally entering the systemic circulation. This process involves the absorption of the drug across the GI tract. The liver is the primary site for metabolizing the drug, with some metabolism also occurring in the gut wall. This journey significantly reduces the quantity of the drug that reaches the systemic circulation, a phenomenon known as...
7.9K
01:22Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
165
Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
165
01:16Bioequivalence: Overview
1.8K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.8K